83 results
8-K/A
EX-99.2
IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares
11 Sep 23
Index to Financial Statements
4:30pm
) The fair value of the assembled workforce was estimated using the replacement cost method using inputs including hiring costs, training costs … to the identified assembled workforce intangible asset acquired in connection with the VectivBio Acquisition.
(ii) Adjustment reflects the reversal of one
8-K
EX-99.1
nuh2pxwqittpuw ja79i
8 Aug 23
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
7:08am
SC TO-T
EX-99
ppkraxhuuntmet748
31 May 23
Third party tender offer statement
6:46am
SC TO-C
EX-99.3
79fxfds81tl6sarh36zz
23 May 23
Information about tender offer
5:26pm
SC TO-C
EX-2.1
99y1eb95
22 May 23
Information about tender offer
4:26pm
8-K
EX-2.1
jb2cmfahk
22 May 23
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
obimz1w9q o1m
17 Feb 22
Results of Operations and Financial Condition
7:06am